Ann Rehabil Med.  2024 Aug;48(4):229-238. 10.5535/arm.240046.

Rehabilitation Strategies for Patients With Spinal Muscular Atrophy in the Era of Disease-Modifying Therapy

• Shin HI

• KMID: 2558729
• DOI: http://doi.org/10.5535/arm.240046

Abstract

The impact of disease-modifying therapy ranges from cure to no impact with a wide range of intermediates. In cases where the intermediate group reaches a plateau after the acquisition of some muscle strength, it is necessary to set a functional level appropriate for increased motor power and establish a long-term exercise plan to maintain it. As the disease status stabilizes and the life span increases, early nonsurgical interventions are required, such as using a standing frame to prevent joint contracture, applying a spinal brace at the early stage of scoliosis, and maintaining sitting postures that exaggerate lumbar lordosis. In cases where scoliosis and hip displacement occur and progress even after conservative managements are implemented, early referral to surgery should be considered. Oromotor activity and swallowing function are influenced not only by the effects of disease-modifying drugs, but also by post-birth experience and training. Therefore, although the feeding tube cannot be removed, it is necessary to make efforts to simulate the infant feeding development while maintaining partial oral feeding. Since the application period of non-invasive ventilators has increased, it has become more important to prevent long-term complications such as facial abrasion, skin allergy, orthodontic deformities, and maxillary flattening caused by the interface. Dual ventilator mode or interface can also be utilized.

Keyword

Spinal muscular atrophy; Disease-modifying therapy; Muscle strength; Oromotor activity; Noninvasive ventilator

Reference

1. Calucho M, Bernal S, Alías L, March F, Venceslá A, Rodríguez-Álvarez FJ, et al. Correlation between SMA type and SMN2 copy number revisited: an analysis of 625 unrelated Spanish patients and a compilation of 2834 reported cases. Neuromuscul Disord. 2018; 28:208–15.

2. Finkel RS, Mercuri E, Darras BT, Connolly AM, Kuntz NL, Kirschner J, ENDEAR Study Group, et al. Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med. 2017; 377:1723–32.

3. Mercuri E, Darras BT, Chiriboga CA, Day JW, Campbell C, Connolly AM, CHERISH Study Group, et al. Nusinersen versus sham control in later-onset spinal muscular atrophy. N Engl J Med. 2018; 378:625–35.

4. Darras BT, Masson R, Mazurkiewicz-Bełdzińska M, Rose K, Xiong H, Zanoteli E, FIREFISH Working Group, et al. Risdiplam-treated infants with type 1 spinal muscular atrophy versus historical controls. N Engl J Med. 2021; 385:427–35.

5. Mercuri E, Muntoni F, Baranello G, Masson R, Boespflug-Tanguy O, Bruno C, STR1VE-EU study group, et al. Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial. Lancet Neurol. 2021; 20:832–41.

6. Tizzano EF, Finkel RS. Spinal muscular atrophy: a changing phenotype beyond the clinical trials. Neuromuscul Disord. 2017; 27:883–9.

7. Mercuri E, Bertini E, Iannaccone ST. Childhood spinal muscular atrophy: controversies and challenges. Lancet Neurol. 2012; 11:443–52.

8. Ramsey D, Scoto M, Mayhew A, Main M, Mazzone ES, Montes J, et al. Revised Hammersmith Scale for spinal muscular atrophy: a SMA specific clinical outcome assessment tool. PLoS One. 2017; 12:e0172346.

9. Mazzone ES, Mayhew A, Montes J, Ramsey D, Fanelli L, Young SD, et al. Revised upper limb module for spinal muscular atrophy: development of a new module. Muscle Nerve. 2017; 55:869–74.

10. Dunaway Young S, Montes J, Kramer SS, Marra J, Salazar R, et al. Six-minute walk test is reliable and valid in spinal muscular atrophy. Muscle Nerve. 2016; 54:836–42.

11. Pera MC, Coratti G, Forcina N, Mazzone ES, Scoto M, Montes J, et al. Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophy. BMC Neurol. 2017; 17:39.

12. Glanzman AM, Mazzone E, Main M, Pelliccioni M, Wood J, Swoboda KJ, et al. The Children’s Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): test development and reliability. Neuromuscul Disord. 2010; 20:155–61.

13. Townsend EL, Simeone SD, Krosschell KJ, Zhang RZ, Swoboda KJ; Project Cure SMA Investigator’s Network. Stander use in spinal muscular atrophy: results from a large natural history database. Pediatr Phys Ther. 2020; 32:235–41.

14. Houwen-van Opstal SLS, Timmer AC, Ten Ham AM, Hosman AJF, Willemsen MAAP, de Groot IJM. Orthopedic interventions for foot deformities in non-ambulant people with Duchenne muscular dystrophy: a retrospective study on indications, post-operative and long-term outcomes. J Neuromuscul Dis. 2022; 9:641–8.

15. Scher DM, Mubarak SJ. Surgical prevention of foot deformity in patients with Duchenne muscular dystrophy. J Pediatr Orthop. 2002; 22:384–91.

16. Wijngaarde CA, Brink RC, de Kort FAS, Stam M, Otto LAM, Asselman FL, et al. Natural course of scoliosis and lifetime risk of scoliosis surgery in spinal muscular atrophy. Neurology. 2019; 93:e149–58.

17. Merlini L, Granata C, Bonfiglioli S, Marini ML, Cervellati S, Savini R. Scoliosis in spinal muscular atrophy: natural history and management. Dev Med Child Neurol. 1989; 31:501–8.

18. Kerr TP, Lin JP, Gresty MA, Morley T, Robb SA. Spinal stability is improved by inducing a lumbar lordosis in boys with Duchenne muscular dystrophy: a pilot study. Gait Posture. 2008; 28:108–12.

19. Duval-Beaupère G, Lespargot A, Grossiord A. Flexibility of scoliosis. What does it mean? Is this terminology appropriate? Spine (Phila Pa 1976). 1985; 10:428–32.

20. Choi YA, Shin HI, Shin HI. Scoliosis in Duchenne muscular dystrophy children is fully reducible in the initial stage, and becomes structural over time. BMC Musculoskelet Disord. 2019; 20:277.

21. McMaster WC, Clayton K. Spinal bracing in the institutionalized person with scoliosis. Spine (Phila Pa 1976). 1980; 5:459–62.

22. Noble-Jamieson CM, Heckmatt JZ, Dubowitz V, Silverman M. Effects of posture and spinal bracing on respiratory function in neuromuscular disease. Arch Dis Child. 1986; 61:178–81.

23. Letts M, Rathbone D, Yamashita T, Nichol B, Keeler A. Soft Boston orthosis in management of neuromuscular scoliosis: a preliminary report. J Pediatr Orthop. 1992; 12:470–4.

24. Nakamura N, Uesugi M, Inaba Y, Machida J, Okuzumi S, Saito T. Use of dynamic spinal brace in the management of neuromuscular scoliosis: a preliminary report. J Pediatr Orthop B. 2014; 23:291–8.

25. Shin HI, Shin HI. Application of fabric-type spinal orthosis for flexible neuromuscular scoliosis: a preliminary study. Am J Phys Med Rehabil. 2020; 99:887–94.

26. Lenhart RL, Youlo S, Schroth MK, Noonan KJ, McCarthy J, Mann D, et al. Radiographic and respiratory effects of growing rods in children with spinal muscular atrophy. J Pediatr Orthop. 2017; 37:e500–4.

27. Nossov SB, Curatolo E, Campbell RM, Mayer OH, Garg S, Cahill APJ; Children’s Spine Study Group. VEPTR: Are we reducing respiratory assistance requirements? J Pediatr Orthop. 2019; 39:28–32.

28. Colombo L, Martini C, Bersanini C, Izzo F, Villafañe JH, Berjano P, et al. Effects of magnetically controlled growing rods surgery on pulmonary function in young subjects with spinal muscular atrophy type 2 and other neuromuscular scoliosis. J Neurosurg Sci. 2020; 64:253–7.

29. Gaume M, Saudeau E, Gomez-Garcia de la Banda M, Azzi-Salameh V, Mbieleu B, Verollet D, et al. Minimally invasive fusionless surgery for scoliosis in spinal muscular atrophy: long-term follow-up results in a series of 59 patients. J Pediatr Orthop. 2021; 41:549–58.

30. Swarup I, MacAlpine EM, Mayer OH, Lark RK, Smith JT, Vitale MG, Pediatric Spine Study Group, et al. Impact of growth friendly interventions on spine and pulmonary outcomes of patients with spinal muscular atrophy. Eur Spine J. 2021; 30:768–74.

31. Ellinger F, Tropp H, Gerdhem P, Hallgren HB, Ivars K. Magnetically controlled growing rod treatment for early-onset scoliosis: analysis of 52 consecutive cases demonstrates improvement of coronal deformity. J Spine Surg. 2023; 9:259–68.

32. Lorenz HM, Hecker MM, Braunschweig L, Badwan B, Tsaknakis K, Hell AK. Continuous lengthening potential after four years of magnetically controlled spinal deformity correction in children with spinal muscular atrophy. Sci Rep. 2020; 10:22420.

33. Ulusaloglu AC, Asma A, Shrader MW, Scavina MT, Mackenzie WG, Erb A, et al. Hip displacement in spinal muscular atrophy: the influences of genetic severity, functional level, and disease-modifying treatments. J Pediatr Orthop. 2024; 44:e226–31.

34. Gibson N, Wynter M, Thomason P, Baker F, Burnett H, Graham HK, et al. Australian hip surveillance guidelines at 10 years: new evidence and implementation. J Pediatr Rehabil Med. 2022; 15:31–7.

35. Battisti N, Cozzaglio M, Faccioli S, Perazza S, Groppi A, Menta L, et al. Prevention of hip dislocation in severe cerebral palsy (GMFCS III-IV-V): an interdisciplinary and multi-professional Care Pathway for clinical best practice implementation. Eur J Phys Rehabil Med. 2023; 59:714–23.

36. Sporer SM, Smith BG. Hip dislocation in patients with spinal muscular atrophy. J Pediatr Orthop. 2003; 23:10–4.

37. Mesfin A, Sponseller PD, Leet AI. Spinal muscular atrophy: manifestations and management. J Am Acad Orthop Surg. 2012; 20:393–401.

38. Ulusaloglu AC, Asma A, Rogers KJ, Shrader MW, Graham HK, Howard JJ. The influence of tone on proximal femoral and acetabular geometry in neuromuscular hip displacement: a comparison of cerebral palsy and spinal muscular atrophy. J Child Orthop. 2022; 16:121–7.

39. Kroksmark AK, Alberg L, Tulinius M, Magnusson P, Söderpalm AC. Low bone mineral density and reduced bone-specific alkaline phosphatase in 5q spinal muscular atrophy type 2 and type 3: a 2-year prospective study of bone health. Acta Paediatr. 2023; 112:2589–600.

40. Baranello G, Vai S, Broggi F, Masson R, Arnoldi MT, Zanin R, et al. Evolution of bone mineral density, bone metabolism and fragility fractures in Spinal Muscular Atrophy (SMA) types 2 and 3. Neuromuscul Disord. 2019; 29:525–32.

41. Vai S, Bianchi ML, Moroni I, Mastella C, Broggi F, Morandi L, et al. Bone and Spinal Muscular Atrophy. Bone. 2015; 79:116–20.

42. Shanmugarajan S, Swoboda KJ, Iannaccone ST, Ries WL, Maria BL, Reddy SV. Congenital bone fractures in spinal muscular atrophy: functional role for SMN protein in bone remodeling. J Child Neurol. 2007; 22:967–73.

43. Wasserman HM, Hornung LN, Stenger PJ, Rutter MM, Wong BL, Rybalsky I, et al. Low bone mineral density and fractures are highly prevalent in pediatric patients with spinal muscular atrophy regardless of disease severity. Neuromuscul Disord. 2017; 27:331–7.

44. Grondard C, Biondi O, Armand AS, Lécolle S, Della Gaspera B, Pariset C, et al. Regular exercise prolongs survival in a type 2 spinal muscular atrophy model mouse. J Neurosci. 2005; 25:7615–22.

45. Chali F, Desseille C, Houdebine L, Benoit E, Rouquet T, Bariohay B, et al. Long-term exercise-specific neuroprotection in spinal muscular atrophy-like mice. J Physiol. 2016; 594:1931–52.

46. Bora G, Subaşı-Yıldız Ş, Yeşbek-Kaymaz A, Bulut N, Alemdaroğlu İ, Tunca-Yılmaz Ö, et al. Effects of arm cycling exercise in spinal muscular atrophy type ii patients: a pilot study. J Child Neurol. 2018; 33:209–15.

47. Lewelt A, Krosschell KJ, Stoddard GJ, Weng C, Xue M, Marcus RL, et al. Resistance strength training exercise in children with spinal muscular atrophy. Muscle Nerve. 2015; 52:559–67.

48. Salem Y, Gropack SJ. Aquatic therapy for a child with type III spinal muscular atrophy: a case report. Phys Occup Ther Pediatr. 2010; 30:313–24.

49. Cunha MC, Oliveira AS, Labronici RH, Gabbai AA. Spinal muscular atrophy type II (intermediary) and III (Kugelberg-Welander). Evolution of 50 patients with physiotherapy and hydrotherapy in a swimming pool. Arq Neuropsiquiatr. 1996; 54:402–6.

50. Mercuri E, Finkel RS, Muntoni F, Wirth B, Montes J, Main M, SMA Care Group, et al. Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord. 2018; 28:103–15.

51. Fehlings DL, Kirsch S, McComas A, Chipman M, Campbell K. Evaluation of therapeutic electrical stimulation to improve muscle strength and function in children with types II/III spinal muscular atrophy. Dev Med Child Neurol. 2002; 44:741–4.

52. PHELPS WM. Prevention of acquired dislocation of the hip in cerebral palsy. J Bone Joint Surg Am. 1959; 41-A:440–8.

53. Catteruccia M, Vuillerot C, Vaugier I, Leclair D, Azzi V, Viollet L, et al. Orthopedic management of scoliosis by Garches brace and spinal fusion in SMA type 2 children. J Neuromuscul Dis. 2015; 2:453–62.

54. Di Pede C, Salamon E, Motta M, Agosto C, Benini F, Ferrari A. Spinal bracing and lung function in type-2 spinal muscular atrophy. Eur J Phys Rehabil Med. 2019; 55:505–9.

55. McGrattan KE, Shell RD, Hurst-Davis R, Young SD, O'Brien E, Lavrov A, et al. Patients with spinal muscular atrophy type 1 achieve and maintain bulbar function following onasemnogene abeparvovec treatment. J Neuromuscul Dis. 2023; 10:531–40.

56. Choi YA, Suh DI, Chae JH, Shin HI. Trajectory of change in the swallowing status in spinal muscular atrophy type I. Int J Pediatr Otorhinolaryngol. 2020; 130:109818.

57. van der Heul AMB, Cuppen I, Wadman RI, Asselman F, Schoenmakers MAGC, van de Woude DR, et al. Feeding and swallowing problems in infants with spinal muscular atrophy type 1: an observational study. J Neuromuscul Dis. 2020; 7:323–30.

58. Wada A, Kawakami M, Liu M, Otaka E, Nishimura A, Liu F, et al. Development of a new scale for dysphagia in patients with progressive neuromuscular diseases: the Neuromuscular Disease Swallowing Status Scale (NdSSS). J Neurol. 2015; 262:2225–31.

59. Yi YG, Oh BM, Yang S, Shin HI. Oral feeding challenges in children with tracheostomy can improve feeding outcomes, even with the finding of aspiration. Front Pediatr. 2019; 7:362.

60. Mason SJ, Harris G, Blissett J. Tube feeding in infancy: implications for the development of normal eating and drinking skills. Dysphagia. 2005; 20:46–61.

61. Mizuno K, Ueda A. Development of sucking behavior in infants who have not been fed for 2 months after birth. Pediatr Int. 2001; 43:251–5.

62. Reilly S, Skuse D, Mathisen B, Wolke D. The objective rating of oral-motor functions during feeding. Dysphagia. 1995; 10:177–91.

63. Gisel EG. Effect of food texture on the development of chewing of children between six months and two years of age. Dev Med Child Neurol. 1991; 33:69–79.

64. Gonski K, Chuang S, Teng A, Thambipillay G, Farrar MA, Menezes MP, et al. Respiratory and sleep outcomes in children with SMA treated with nusinersen - real world experience. Neuromuscul Disord. 2023; 33:531–8.

65. Pechmann A, Behrens M, Dörnbrack K, Tassoni A, Stein S, Vogt S, SMArtCARE study group, et al. Effect of nusinersen on motor, respiratory and bulbar function in early-onset spinal muscular atrophy. Brain. 2023; 146:668–77.

66. Kant-Smits K, Hulzebos EHJ, Habets LE, Asselman FL, Veldhoen ES, van Eijk RPA, et al. Respiratory muscle fatigability in patients with spinal muscular atrophy. Pediatr Pulmonol. 2022; 57:3050–9.

67. Bach JR, Ishikawa Y, Kim H. Prevention of pulmonary morbidity for patients with Duchenne muscular dystrophy. Chest. 1997; 112:1024–8.

68. Chatwin M, Ross E, Hart N, Nickol AH, Polkey MI, Simonds AK. Cough augmentation with mechanical insufflation/exsufflation in patients with neuromuscular weakness. Eur Respir J. 2003; 21:502–8.

69. Fauroux B, Guillemot N, Aubertin G, Nathan N, Labit A, Clément A, et al. Physiologic benefits of mechanical insufflation-exsufflation in children with neuromuscular diseases. Chest. 2008; 133:161–8.

70. Ward S, Chatwin M, Heather S, Simonds AK. Randomised controlled trial of non-invasive ventilation (NIV) for nocturnal hypoventilation in neuromuscular and chest wall disease patients with daytime normocapnia. Thorax. 2005; 60:1019–24.

71. Amaddeo A, Moreau J, Frapin A, Khirani S, Felix O, Fernandez-Bolanos M, et al. Long term continuous positive airway pressure (CPAP) and noninvasive ventilation (NIV) in children: initiation criteria in real life. Pediatr Pulmonol. 2016; 51:968–74.

72. Nicot F, Hart N, Forin V, Boulé M, Clément A, Polkey MI, et al. Respiratory muscle testing: a valuable tool for children with neuromuscular disorders. Am J Respir Crit Care Med. 2006; 174:67–74.

73. Fauroux B, Griffon L, Amaddeo A, Stremler N, Mazenq J, Khirani S, et al. Respiratory management of children with spinal muscular atrophy (SMA). Arch Pediatr. 2020; 27(7S):7S29–34.

74. Fauroux B, Aubertin G, Cohen E, Clement A, Lofaso F. Sniff nasal inspiratory pressure in children with muscular, chest wall or lung disease. Eur Respir J. 2009; 33:113–7.

75. Choi YH, Kim MS, Kim CH, Song IG, Park JD, In Suh D, et al. Looking into the life of technology-dependent children and their caregivers in Korea: lifting the burden of too many responsibilities. BMC Pediatr. 2020; 20:486.